Delivery Order 36C24626D0014-36C24626N0194
- Not listed
- This delivery order, awarded on October 1, 2025, to Cepheid Inc. for $299,404 provides molecular diagnostic testing system reagents and assays to Veterans Integrated Service Network (VISN) 6 through March 31, 2026. The contract utilizes a firm fixed-price structure with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will supply products and services supporting infectious disease detection and clinical testing across VISN 6's...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 6 awarded a delivery order to Cepheid Inc. for Cepheid Molecular Diagnostic Testing System Reagents and Assays valued at $537,017.20, effective October 1, 2025, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was awarded without set-aside designation and represents a task order issued under Cepheid's larger IDV vehicle with VISN 6, which holds a total ceiling value of $32.8...
- Cepheid Inc., a leading manufacturer of molecular diagnostic systems based in Sunnyvale, California, was awarded a delivery order valued at $970,216.62 on October 1, 2025, for Cepheid Molecular Diagnostic Testing System reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6). This firm fixed-price delivery order, which extends through March 31, 2026, carries no set-aside designation and will be performed in Sunnyvale, California. The award funds the supply of molecular...
- Cepheid has been awarded a delivery order valued at $341,103.30 for Cepheid Molecular Diagnostic Testing System Reagents and Assays under the Veterans Integrated Service Network (VISN) 6 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. This firm fixed-price delivery order was awarded on October 14, 2025, with an ultimate completion date of March 31, 2026. The contract carries no set-aside designation and is funded by the Department of Veterans Affairs through VISN 6. Cepheid, a...
- The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain division, awarded a $28,786 firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This non-set-aside contract is issued under Cepheid's existing Indefinite Delivery Vehicle (IDV) with the Veterans Integrated Service Network (VISN) 6, a $32.8 million single-award contract that extends through September 30, 2030. The work will be performed at...
- This delivery order, awarded on October 1, 2025, represents a $465,517 firm fixed-price contract between the Department of Veterans Affairs Veterans Integrated Service Network 6 (VISN 6) and Cepheid Inc. for molecular diagnostic testing system reagents and assays. The contract extends through March 31, 2026, and is issued under VISN 6's larger Indefinite Delivery Indefinite Quantity (IDIQ) vehicle valued at $32.8 million through September 30, 2030. This delivery order carries no set-aside...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a delivery order to Cepheid Inc. valued at $115,369.40 for Cepheid GeneXpert Infinity molecular reagents. The contract, awarded on October 1, 2025, has a firm fixed-price structure with an ultimate completion date of March 31, 2026. This delivery order carries no set-aside designation and represents procurement under an existing Indefinite Delivery Vehicle, enabling VISN 8 to obtain molecular diagnostic testing...
- This delivery order, valued at $27.2K, was awarded on September 3, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The order is a firm fixed-price award with an ultimate completion date of September 10, 2025, funded by the Medical Supply Chain division within the Department of Defense. The contract carries no set-aside designation and is to be performed in Sunnyvale, California. This delivery order falls under Cepheid's existing Indefinite...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a delivery order to Cepheid Inc. for a molecular analyzer lease and cost-per-test arrangement with a ceiling value of $1.23M and an ultimate completion date of January 18, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger Indefinite Delivery Vehicle (IDV) contract. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic...
- Cepheid has been awarded a delivery order valued at approximately $310K for molecular diagnostic testing system reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6), a component of the Department of Veterans Affairs' healthcare system. This firm fixed-price delivery order, with no set-aside designation, will be performed through March 31, 2026, and represents a continuation of Cepheid's ongoing supply of diagnostic solutions to the VA's regional health networks. The...
- 36C24626D0014Indefinite Delivery Contract
- 36C24626D0014-36C24626N0194Delivery Order
This delivery order, awarded on October 1, 2025, provides maintenance and service support for Cepheid GeneXpert diagnostic systems deployed within the Department of Veterans Affairs (VA) Veterans Integrated Service Network 6, which serves the VA medical facilities in North Carolina and surrounding regions. The contract is valued at $37,284 on a firm fixed-price basis with an ultimate completion date of September 30, 2026. The work will be performed in Salisbury, North Carolina, and represents a no-set-aside competitive award to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order is issued under Cepheid's larger indefinite delivery vehicle contract with VA VISN 6, valued at approximately $32.8 million through September 2030, which provides the GeneXpert systems, reagents, and assays that support comprehensive molecular diagnostic testing across the network's facilities. The GeneXpert platform is utilized by VA VISN 6 to conduct rapid, point-of-care molecular testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other clinical conditions requiring molecular confirmation. As a manufacturer with extensive federal contracting experience across multiple VA networks, the Defense Logistics Agency, and the Defense Health Agency, Cepheid provides critical diagnostic infrastructure that enables VA healthcare providers to deliver timely and accurate patient care. The service contract ensures continuity of diagnostic capabilities through the planned maintenance and support of these systems during the performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.3k | 10/1/25 |